ReviewCurrent oncology reports2013

Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?

Morgan Trammel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.